The Next Generation Biotech Media
Just when nations worldwide would have anticipated ending the year on a high with the recently approved COVID-19 vaccines, a new fast-spreading coronavirus variant, named B.1.1.7 (VUI-202012/01) has debuted on …
Read More
December 2, 2020 – In a major breakthrough in the COVID-19 vaccine race, the Medicines & Healthcare Products Regulatory Agency (MHRA) of the United Kingdom has given an emergency authorization …
Read More
November 23, 2020 – As we approach the end of the year, companies working on COVID-19 vaccines have started rolling out data from their Phase 3 trials – first Pfizer …
Read More
As COVID-19 continues to snowball into a massive health and economic concern, the world is anxiously anticipating a vaccine. While Russia’s vaccine was approved in August, several biopharma giants worldwide …
Read More
On August 4th, nearly two months since the inception of vaccine testing, Novavax announced preliminary data from its Phase 1 trial. The vaccine produced a promising immune response in the …
Read More
By Judy Ya-Hsuan Lin The clinical-stage biotech which hasn’t launched any product in the market previously is gearing towards an ambitious deadline to counter the COVID-19 pandemic. Maryland-based Novavax is …
Read More
By Sahana Shankar, Ph.D. Candidate As opposed to antibodies that bind to the receptor-binding domain, scientists discover a new antibody that binds to the N-Terminal Domain of the SARS-CoV-2’s spike …
Read More
By Ruchi Jhonsa, Ph.D. The BIO Digital Conference held between June 8-12, saw over 7000 participants from 64 countries come together for a two-day virtual meeting to discuss the progress …
Read More
By Sahana Shankar, Ph.D. Candidate European researchers report that SARS-CoV-2’s entry into the host cells is facilitated by Neuropilin-1 (NRP1), a cell receptor that, when inhibited with a monoclonal antibody, …
Read More
By Ruchi Jhonsa, Ph.D. While the vaccine’s effectiveness in humans is still in question, Novavax is already flooded with cash flow from various sources for the testing and development of …
Read More